Evidence for efficacy is mixed, with some studies showing benefit and others showing no effect
GLP-1 receptor agonists reduce inflammatory cytokines, improve insulin resistance, aid gut health, and help lower the chronic inflammation that drives many forms of arthritis, as well as metabolic and heart diseases. Are GLP-1 medications safe, and who should not use them
So the question is: Is there going to be increased pressure on the starting doses of tirzepatide and semaglutide? The restrictions on compounded GLP-1 products come as concerns about existing shortages are bubbling
Improved eGFR is generally a sign that the kidneys are filtering waste effectively
Repetition is necessary to completely cover your body
For people who notice an energy boost or feel more motivated on certain days relative to their injection schedule, there is no harm in aligning training with those days